Abstract
Early diagnosis of bacterial pneumonia plays a pivotal role in the management. We evaluated the diagnostic accuracy of procalcitonin (PCT) as compared with C‐reactive protein (CRP) for the early diagnosis of bacterial pneumonia in children. In total, 92 children consisting of 46 patients of bacterial pneumonia were admitted in the Military hospital, Rawalpindi, Pakistan and equal number of controls were included. Patient's investigations were carried out at admission. PCT and CRP were analyzed on Vidas analyzer and Immulite 1000, respectively. Out of 46 pneumonia patients, 28 were male and 18 female, with a median age of 4 years. PCT levels were significantly high median (range) of 2.69 ng/ml (0.30–13.00) vs. 0.45 ng/ml (0.10–2.00) in controls. Serum CRP levels were moderately elevated with median (range) 6.5 mg/l (0.30–60) vs. 0.30 mg/l (0.30–5.0) in controls. The area under receiver characteristic curves for PCT and CRP were 0.89 (95% CI=0.83–0.96) and 0.79 (95% CI=0.70–0.88), respectively. In total, 38 patients were diagnosed to have bacterial pneumonia with PCT (sensitivity 83% at cutoff ≥1 ng/ml) and 26 children with CRP (sensitivity 57% at cutoff ≥6 mg/L). PCT has better diagnostic accuracy than CRP and can be utilized for early diagnosis of bacterial pneumonia in children. J. Clin. Lab. Anal. 24:1–5, 2010. © 2010 Wiley‐Liss, Inc.
Keywords: procalcitonin, C‐reactive protein, bacterial pneumonia, diagnostic accuracy, sensitivity, specificity, children
REFERENCES
- 1. World Health Organization , Health Report 2004. www.who.org.
- 2. BTS Guidelines for the Management of Community Acquired Pneumonia in Childhood. Thorax 2002;57:1–24.11809978 [Google Scholar]
- 3. Gendrel D, Raymond J, Coste J, et al. Comparison of procalcitonin with C‐reactive protein, interleukin 6 and interferon‐alpha for differentiation of bacterial vs. viral infections. Pediatr Infectious Dis J 1999;18:875–881. [DOI] [PubMed] [Google Scholar]
- 4. Thayyil S, Shenoy M, Hamaluba M, Gupta A, Frater J, Verber IG. Is procalcitonin useful in early diagnosis of serious bacterial infections in children? Acta Paediatr 2005;94:155–158. [DOI] [PubMed] [Google Scholar]
- 5. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79:1605–1608. [DOI] [PubMed] [Google Scholar]
- 6. Christ‐Crain M, Muller B. Procalcitonin in bacterial infections—Hype, hope, more or less? Swiss Med Wkly 2005;135:451–460. [DOI] [PubMed] [Google Scholar]
- 7. Brunkhorst FM, Heinz U, Forycki ZF. Kinetics of procalcitonin in iatrogenic sepsis [letter]. Intensive Care Med 1998;24:888–889. [DOI] [PubMed] [Google Scholar]
- 8. Nijsten MW, Olinga P, The TH, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000;28:458–461. [DOI] [PubMed] [Google Scholar]
- 9. Moulin F, Raymond J, Lorrot M, et al. Procalcitonin in children admitted to hospital with community‐acquired pneumonia. Arch Dis Child 2001;84:332–336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Nohynek H, Eskola J, Kleemola M, Jalonen E, Saikku P, Leinonen M. Bacterial antibody assays in the diagnosis of acute lower respiratory tract infection in children. Pediatr Infect Dis 1995;14:478–484. [DOI] [PubMed] [Google Scholar]
- 11. Kenny GE, Grayston JT. Eaton pleuropneumonia‐like organism (Mycoplasma pneumoniae) complement‐fixing antigen: Extraction with organic solvents. J Immunol 1965;95:19–25. [PubMed] [Google Scholar]
- 12. Roberts WL, Sedrick R, Moulton L, Spencer A, Rifai N. Evaluation of four automated high‐sensitivity C‐reactive protein methods: Implications for clinical and epidemiological applications. Clin Chem 2000;46:461–468. [PubMed] [Google Scholar]
- 13. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839–848. [DOI] [PubMed] [Google Scholar]
- 14. Jean‐Paul M, Adeline M, Pierre‐Regis B. The role of biomarkers in community‐acquired pneumonia: predicting mortality and response to adjunctive therapy. Critical Care 2008;12:S5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Don M, Fasoli L, Paldanius M, et al. M. Aetiology of community‐acquired pneumonia: Serological results of a pediatric survey. Scand J Infect Dis 2005;37:806–812. [DOI] [PubMed] [Google Scholar]
- 16. Simon L, Gauvin F, Amre DK, Saint‐Louis P, Lacroix J. Serum procalcitonin and C‐reactive protein levels as markers of bacterial infection: A systematic review and meta‐analysis. Clin Infect Dis 2004;39:206–217. [DOI] [PubMed] [Google Scholar]
- 17. Ip M, Rainer HT, Lee N, et al. Value of serum procalcitonin, neopterin, and C‐reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections. Diagn Microbiol Infect Dis 2007;59:131–136. [DOI] [PubMed] [Google Scholar]
- 18. Toikka P, Irjala K, Juven T, et al. Serum procalcitonin, C‐reactive protein and interleukin‐6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000;19:596–602. [DOI] [PubMed] [Google Scholar]
- 19. Sanders S, Barnett A, Correa‐Velez I, Coulthard M, Doust J. Systematic review of the diagnostic accuracy of C‐reactive protein to detect bacterial infection in nonhospitalized infants and children with fever. J Pediatr 2008;153:570–574. [DOI] [PubMed] [Google Scholar]
- 20. Heiskanen‐Kosma T, Korppi M, Jokinen C, et al. Etiology of childhood pneumonia: Serological results of a prospective, population‐based study. Pediatr Infect Dis J 1998;17:986–991. [DOI] [PubMed] [Google Scholar]
- 21. Flood RG, Badik J, Aronoff SC. The utility of serum C‐reactive protein in differentiating bacterial from nonbacterial pneumonia in children: A meta‐analysis of 1230 children. Pediatr Infect Dis J 2008;27:95–99. [DOI] [PubMed] [Google Scholar]
- 22. Korppi M. Non‐specific host response markers in the differentiation between pneumococcal and viral pneumonia: What is the most accurate combination? Pediatr Int 2004;46:545–550. [DOI] [PubMed] [Google Scholar]